Canadian Online Pharmacy

CDER New August 12, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 11, 2014


New and Generic Drug Approvals

August 8, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Capecitabine capecitabine Tablet;Oral Mylan Pharms Inc Approval
Farxiga dapagliflozin Tablet;Oral Astrazeneca Ab Labeling Revision
Invokamet canagliflozin and metformin hydrochloride Tablet; Oral Janssen Pharms Approval
Juxtapid lomitapide mesylate Capsule;Oral Aegerion Labeling Revision
Silenor doxepin hydrochloride Tablet;Oral Pernix Theraps Llc Manufacturing Change or Addition
Velcade bortezomib Injectable;Intravenous, Subcutaneous Millennium Pharms Efficacy Supplement with Clinical Data to Support
Videx didanosine For Solution;Oral Bristol Myers Squibb Labeling Revision
Xanax alprazolam Tablet;Oral Pharmacia and Upjohn Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery